These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3097715)

  • 21. Evaluation of epileptic dogs as an animal model of human epilepsy.
    Löscher W; Schwartz-Porsche D; Frey HH; Schmidt D
    Arzneimittelforschung; 1985; 35(1):82-7. PubMed ID: 4039156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients.
    Babaei A; Eslamai MH
    Int J Clin Pharmacol Ther; 2007 Feb; 45(2):121-5. PubMed ID: 17323792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative pharmacokinetic study of conventional and sustained-release viloxazine in normal volunteers.
    Kergueris MF; Bourin M; Ribeyrol M; Beneroso N; Normand YL; Larousse C
    Neuropsychobiology; 1989; 20(3):136-40. PubMed ID: 2761683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of valproic acid and enzyme-inducing anticonvulsants on nimodipine pharmacokinetics in epileptic patients.
    Tartara A; Galimberti CA; Manni R; Parietti L; Zucca C; Baasch H; Caresia L; Mück W; Barzaghi N; Gatti G
    Br J Clin Pharmacol; 1991 Sep; 32(3):335-40. PubMed ID: 1777370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Synopsis of psychopathological, electroencephalographical, and pharmacokinetic variables during antidepressive treatment with viloxazine (author's transl)].
    Busch H; Bente D; Müller-Oerlinghausen B; Renfordt E
    Arzneimittelforschung; 1978; 28(8):1288-90. PubMed ID: 380579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come?
    Perucca E; Johannessen SI
    Epileptic Disord; 2003 May; 5 Suppl 1():S17-26. PubMed ID: 12915337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stiripentol kinetics in epilepsy: nonlinearity and interactions.
    Levy RH; Loiseau P; Guyot M; Blehaut HM; Tor J; Moreland TA
    Clin Pharmacol Ther; 1984 Nov; 36(5):661-9. PubMed ID: 6488687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substituting carbamazepine with oxcarbazepine increases citalopram levels. A report on two cases.
    Leinonen E; Lepola U; Koponen H
    Pharmacopsychiatry; 1996 Jul; 29(4):156-8. PubMed ID: 8858715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of administration route on pharmacokinetics of viloxazine in the rabbit.
    Thomare P; Bourin M; Kergueris MF; Ortega A; Larousse C
    Methods Find Exp Clin Pharmacol; 1992 Mar; 14(2):125-9. PubMed ID: 1598024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of diazepam in epileptic patients and normal volunteers following intravenous administration.
    Dhillon S; Richens A
    Br J Clin Pharmacol; 1981 Dec; 12(6):841-4. PubMed ID: 6803820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One-step extraction procedure for gas chromatographic determination of viloxazine as its acetyl derivative in human plasma.
    Groppi A; Papa P
    J Chromatogr; 1985 Jan; 337(1):142-5. PubMed ID: 3980644
    [No Abstract]   [Full Text] [Related]  

  • 32. Non-monoamine oxidase inhibitor antidepressants and epilepsy: a review.
    Trimble M
    Epilepsia; 1978 Jun; 19(3):241-50. PubMed ID: 354920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.
    McKee PJ; Blacklaw J; Forrest G; Gillham RA; Walker SM; Connelly D; Brodie MJ
    Br J Clin Pharmacol; 1994 Jan; 37(1):27-32. PubMed ID: 8148215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute and chronic treatment with mianserin differentially affects the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model.
    Borowicz KK; Banach M; Zarczuk R; Lukasik D; Luszczki JJ; Czuczwar SJ
    Psychopharmacology (Berl); 2007 Dec; 195(2):167-74. PubMed ID: 17653694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal insensitivity to frusemide caused by chronic anticonvulsant therapy.
    Ahmad S
    Br Med J; 1974 Sep; 3(5932):657-9. PubMed ID: 4609534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs.
    Perucca E; Richens A
    Br J Clin Pharmacol; 1979 Feb; 7(2):201-6. PubMed ID: 760753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and bioavailability of viqualine, a new antidepressant.
    Fourtillan JB; Bouquet S; Girault J; Lefebvre MA; Maulet C; Courtois P
    Eur J Drug Metab Pharmacokinet; 1985; 10(1):3-10. PubMed ID: 4029218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Affective disorder and epilepsy comorbidity: implications for development of treatments, preventions and diagnostic approaches.
    Jobe PC
    Clin EEG Neurosci; 2004 Jan; 35(1):53-68. PubMed ID: 15112464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid.
    Tartara A; Galimberti CA; Manni R; Morini R; Limido G; Gatti G; Bartoli A; Strada G; Perucca E
    Br J Clin Pharmacol; 1993 Oct; 36(4):366-8. PubMed ID: 12959317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choice and use of newer anticonvulsant drugs in older patients.
    Willmore LJ
    Drugs Aging; 2000 Dec; 17(6):441-52. PubMed ID: 11200305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.